Welcome to our dedicated page for Bath & Body Works SEC filings (Ticker: BBWI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bath & Body Works, Inc. (NYSE: BBWI) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8‑K that furnish earnings releases and guidance updates. Recent 8‑K filings reference press releases detailing unaudited quarterly financial results, outlook for upcoming quarters and revisions to full-year guidance, which are incorporated by reference as exhibits.
Through these filings, investors can review information on net sales, operating income, net income and earnings per diluted share, as well as management’s commentary on business trends and strategic initiatives. Bath & Body Works uses 8‑K filings to distribute its quarterly results and to provide context on its Consumer First Formula transformation plan, which focuses on product innovation, brand building, marketplace expansion and operating efficiency.
On Stock Titan, BBWI filings are updated in near real time from the SEC’s EDGAR system and are paired with AI-powered summaries that explain the key points in clear language. These tools help readers quickly understand what each filing covers, such as changes in guidance, notable adjustments in reported versus adjusted results, or other material events disclosed under Regulation FD.
In addition to 8‑K reports, investors can use this page to locate Bath & Body Works’ periodic filings like annual reports on Form 10‑K and quarterly reports on Form 10‑Q, when available, for deeper detail on segment performance, risk factors and accounting policies. Insider transaction reports on Form 4, once filed, can also be accessed to analyze equity activity by directors and officers. The combination of original documents and AI-generated insights is intended to make BBWI’s regulatory history easier to navigate and interpret.
Bath & Body Works, Inc. director reports open-market share purchase. A company director filed a Form 4 disclosing the purchase of 22,500 shares of Bath & Body Works common stock on 11/24/2025 at a weighted average price of $15.58 per share. After this transaction, the reporting person beneficially owns 40,379 common shares held directly. The filing notes that the purchase price reflects a weighted average, with individual trades executed between $15.575 and $15.58 per share, and that detailed trade-level pricing information will be made available upon request.
Bath & Body Works, Inc. (BBWI) director reported buying additional company stock. On 11/24/2025, the reporting person purchased 10,000 shares of common stock at a price of $15.58 per share. After this transaction, the director beneficially owned 285,522 shares, held directly. The filing is signed by an attorney-in-fact on behalf of the reporting person.
Bath & Body Works, Inc. (BBWI) director purchased additional company stock in the open market. On 11/21/2025, the reporting person bought 20,000 shares of common stock at a price of $15.035 per share, coded as a purchase transaction ("P").
After this transaction, the director beneficially owned 33,925 shares of Bath & Body Works common stock, held directly. The filing notes that the form was submitted for a single reporting person and was signed by an attorney-in-fact on 11/24/2025.
Bath & Body Works, Inc. (BBWI) director reported an open-market stock purchase. On 11/21/2025, the director bought 6,700 shares of common stock at a price of $14.855 per share. After this transaction, the director directly owns 48,175 shares of BBWI common stock. Additional indirect holdings include 12,925 shares held by the director's spouse and 9,900 shares each held in the Patricia M. Steinour Legacy Trust dated 10/14/2016 and the Stephen D. Steinour Dynasty Trust dated 6/1/2016. No derivative securities were reported.
Bath & Body Works, Inc. (BBWI) director reports open-market stock purchase. A director acquired 3,343 shares of common stock of Bath & Body Works, Inc. on 11/21/2025 in a reported purchase transaction at a price of $14.995 per share. Following this transaction, the director directly holds 21,554 shares of BBWI common stock. This filing is a routine Form 4 disclosure of insider share ownership and recent trading activity.
Bath & Body Works, Inc. (BBWI)3,469.552 shares of Bath & Body Works common stock at a weighted average price of
After this transaction, the director beneficially owns 17,481.552 shares held directly. The price represents a weighted average, with individual purchase prices ranging from
Bath & Body Works (BBWI) reported a weaker third quarter of 2025 and outlined a major turnaround plan. Net sales slipped to $1.594 billion from $1.610 billion as stronger store and international sales could not offset a 7% decline in direct channel revenue. Gross margin compressed to 41.3% from 43.5% due to tariffs and heavier promotions, while operating income fell to $161 million from $218 million. Net income dropped to $77 million, or $0.37 per diluted share, versus $106 million, or $0.49, a year earlier.
Year-to-date, sales edged up 1.1% to $4.567 billion, but operating income and net income declined to $527 million and $246 million, respectively. The company generated $225 million of operating cash flow, spent $174 million on capex, repurchased $343 million of stock, and paid $126 million in dividends, ending the period with $236 million in cash and $3.890 billion of long-term debt. Management launched “The Consumer First Formula,” targeting $250 million of cost savings over the next two years to fund growth initiatives in product, brand, and marketplace expansion.
Bath & Body Works, Inc. reported that it has released its unaudited financial results for the third quarter of 2025 and provided earnings guidance for the fourth quarter of 2025. The company also updated its earnings guidance for the full year 2025, giving investors a view of how management currently expects the rest of the year to unfold.
These details are contained in a press release dated November 20, 2025, which is included as an exhibit to this report and incorporated by reference. The information is being furnished under the sections covering results of operations and Regulation FD disclosure, meaning it is intended to keep the market broadly informed but is not treated as being formally filed under certain liability provisions.
Bath & Body Works Inc. (BBWI) — Schedule 13G/A update: FMR LLC and Abigail P. Johnson filed Amendment No. 1 reporting beneficial ownership of 17,176,068.05 shares of BBWI common stock, representing 8.3% of the class as of the event date.
FMR reports sole voting power over 17,065,906.57 shares and sole dispositive power over 17,176,068.05 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over 17,176,068.05 shares and no voting power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The date of event is September 30, 2025. The filing notes that one or more other persons may have rights to dividends or sale proceeds, and that no single such interest exceeds 5% of the class.
Victory Capital Management, Inc. filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 8,405,430 shares of Bath & Body Works (BBWI) common stock, representing 4.08% of the class as of 09/30/2025.
The filer reports sole voting power over 8,240,779 shares and sole dispositive power over 8,405,430 shares, with no shared voting or dispositive power. The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
FAQ
What is the current stock price of Bath & Body Works (BBWI)?
What is the market cap of Bath & Body Works (BBWI)?
